Startseite>>Isotope-Labeled Compounds>>N-Valerylglycine-d2

N-Valerylglycine-d2

Katalog-Nr.GC72641

N-Valerylglycine-d2 is the deuterated labeled N-Valerylglycine .

Products are for research use only. Not for human use. We do not sell to patients.

N-Valerylglycine-d2 Chemische Struktur

Cas No.: 3008541-76-9

Größe Preis Lagerbestand Menge
1 mg
162,00 $
Auf Lager
5 mg
405,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
N-Valerylglycine-d2 is the deuterated labeled N-Valerylglycine . N-Valerylglycine is a Glycine derivative.

Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1].
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].

References:
[1]. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

Bewertungen

Review for N-Valerylglycine-d2

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-Valerylglycine-d2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.